Physician Education: Bridging Clinical Research and Patient Care

Topics in Antiviral Medicine: Previous Issues

Previous issues of the publication are available here in PDF format (Adobe Acrobat Reader 4.0 or higher needed to view). Health care providers may receive a complimentary subscription to Topics in Antiviral Medicine.

Volume 26

Volume 25

  • April 2018 (Issue 4) : HIV Infection: Advances Toward a Cure; Investigational Antiretroviral Drugs: What is Coming Down the Pipeline; Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease; Maximizing the Benefits of HIV Preexposure Prophylaxis; Opioids and HIV Infection: From Pain Management to Addiction Treatment
  • July/August 2017 (Issue 3) : Neurologic Complications in Persons With HIV Infection in the Era of Antiretroviral Therapy; Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens; Barriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series; Sustained Off-Treatment Response After Discontinuation of Long-Term Nucleos(t)ide Analogue Treatment in HBeAg-Seronegative Hepatitis B: A Case Series
  • May/June 2017 (Issue 2) : Highlights of the 2017 Conference on Retroviruses and Opportunistic Infections
  • April 2017 (Special Issue) (Issue 1s) : CROI 2017 Abstracts
  • February/March 2017 (Issue 1) : Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time; Management of Advanced Fibrosis in the Context of Hepatitis C Virus Infection; Kidney Disease and HIV Infection; HIV Treatment and Prevention: An Overview of Recommendations From the 2016 IAS-USA Antiretroviral Guidelines Panel

Volume 24

  • December 2016/January 2017 (Issue 4) : HIV Prevention: Opportunities and Challenges; Cardiovascular Complications of HIV Infection; 2017 Update of the Drug Resistance Mutations in HIV-1; A Conversation Among the IAS–USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care
  • October/November 2016 (Issue 3) : Clinically Significant Drug-Drug Interactions Between Hepatitis C Virus and HIV Treatments; Sexually Transmitted Infections in the Context of HIV Disease: Clinical Implications; Elements of the HIV Care Continuum: Improving Engagement and Retention in Care
  • July/August 2016 (Issue 2) : HIV Infection in Hard-to-Reach Populations; HIV Transmission and Injection Drug Use; Understanding Cost and Value in Hepatitis C Therapy; The Affordable Care Act in the United States and HIV Disease
  • June 2016 (Issue e-1) : CROI 2016 Abstracts
  • May/June 2016 (Issue 1) : Highlights of the 2016 Conference on Retroviruses and Opportunistic Infections

Volume 23

  • December 2015/January 2016 (Issue 5) : Treatment of Acute HIV Infection and the Potential Role of Acutely HIV-Infected Persons in Cure Studies; Antiretroviral Therapy for HIV Infection; Management of Lipid Levels and Cardiovascular Disease in HIV-Infected Individuals; Advance Care Planning and HIV Infection in the Era of Antiretroviral Therapy
  • October/November 2015 (Issue 4) : 2015 Update of the Drug Resistance Mutations in HIV-1; Choosing Initial Antiretroviral Therapy; Screening for Human Papillomavirus–Associated Cervical Disease in HIV-Infected Women; HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial
  • August/September 2015 (Issue 3) : What Can We Learn From Measles? No New HIV Infections; Management of the HBV/HIV–Coinfected Patient; HIV-Related Opportunistic Infections Are Still Relevant in 2015; Chronic Pain in Patients With HIV Infection
  • May/June 2015 (Issue 2) : What Will It Take To Cure HIV?; Preexposure Prophylaxis For HIV Prevention; HCV Direct-Acting Antiviral Drug Interactions and Use in Renal and Hepatic Impairment; Care of the Older Adult With HIV Infection
  • July 2015 (Issue e-1) : CROI 2015 Abstracts
  • March/April 2015 (Issue 1) : Highlights of the 2015 Conference on Retroviruses and Opportunistic Infections

Volume 22

  • December 2014/January 2015 (Issue 5) : Highlights of the 2014 International AIDS Conference; What's New in Sexually Transmitted Infections in the HIV Care Setting; HIV Prevention
  • September/October 2014 (Issue 4) : HIV Preexposure Prophylaxis in the Real World; Cardiovascular Disease in HIV; The Skin and HIV: No Superficial Matter; Cirrhosis in HCV-Infected Patients
  • June/July 2014 (Issue 3) : 2014 Update of the Drug Resistance Mutations in HIV-1; Metabolic Complications of HIV Infection and Its Therapies; Antiretroviral Therapy and the Kidney; Non–AIDS-Defining Cancers
  • May 2014 (Issue 2) : Highlights of the 2014 Conference on Retroviruses and Opportunistic Infections
  • April 2014 (Issue e-1) : CROI 2014 Abstracts

Volume 21

  • December 2013/January 2014 (Issue 5) : The Fragile Relationship Between HCV and Its Human Host; Cure of HCV Infection Without Interferon Alfa; An Update on Hepatitis B, D, and E Viruses; Ergotism in Thailand Caused by Increased Access to Antiretroviral Drugs
  • September/October 2013 (Issue 4) : Immune Activation, HIV Persistence, and the Cure; Linkage, Engagement, and Retention in HIV Care Among Vulnerable Populations; Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program
  • July/August 2013 (Issue 3) : Treament as Prevention; Challenges in the Management of Osteoporosis and Vitamin D Deficiency in HIV Infection; HIV, Aging, and Cognition; Neurologic Complications of HIV Infection: Highlights From CROI 2013
  • April/May 2013 (Issue 2) : Highlights of the 20th Conference on Retroviruses and Opportunistic Infections
  • February/March 2013 (Issue 1) : Update of the Drug Resistance Mutations in HIV-1; The Hidden Epidemic of HCV Infection in the US; The Role of Palliative Care in the Current HIV Treatment Era in Developed Countries; Impact of New Therapeutics for HCV Infection in Incarcerated Populations

Volume 20

  • December 2012/January 2013 (Issue 5) : Management of HCV Infection; New and Investigational Antiretroviral Drugs for HIV Infection; Vitamin D, Bone, and HIV Infection; Epidermodysplasia Verruciformis in an HIV-Infected Man; Highlights of the 2012 AASLD Meeting
  • October/November 2012 (Issue 4) : Managing Adverse Effects and Complications in Completing Treatment for HCV Infection; Cardiovascular Risk and Dyslipidemia Management in HIV-Infected Patients; Cardiovascular Risk and Dyslipidemia Management in HIV-Infected Patients; Syphilis Negatively Influences the Response to HCV Treatment in an HIV-Infected Patient
  • August/September 2012 (Issue 3) : Aging and HIV Infection; Acute Kidney Injury; Travelers With Limited Immunodeficiency
  • June/July 2012 (Issue 2) : Highlights of the 19th Conference on Retroviruses and Opportunistic Infections
  • April/May 2012 (Issue 1) : Advances in the Treatment of Hepatitis C Virus Infection; Sexually Transmitted Infections and HIV; Editorial: Hepatitis C Virus Therapeutics

Volume 19

  • December 2011/January 2012 (Issue 5) : Predicting and Preventing Cardiovascular Disease in HIV-Infected Patients; Evaluating Cognitive Impairment in the Clinical Setting; HIV Preexposure Prophylaxis; Update of the Past Year: A Review from IDSA 2011
  • November 2011 (Issue 4) : CNS Complications; Addressing Alcohol Use in HIV-Infected Persons; Conception Interventions in RCS; HIV Drug Resistance Mutations Update
  • August/September 2011 (Issue 3) : HCV Replication; Advanced Liver Disease; ARV Formulations without Pills
  • May/June 2011 (Issue 2) : CROI Highlights -- Basic Science, Vaccines, Epidemiology, CNS Complications, ARV
  • February/March 2011 (Issue 1) : Vitamin D, Retention in Care, HIV Diagnostic Technologies, Perinatal Transmission Prevention

Volume 18

  • December 2010 (Issue 5) : Cardiovascular Disease Risk Factors; Occupational Postexposure Prophylaxis; Drug Resistance Mutations: 2010; Molluscum Contagiosum
  • October/November 2010 (Issue 4) : Investigational Drugs for HCV Infection; STIs and HIV; Tuberculosis and HIV Coinfection
  • August/September 2010 (Issue 3) : Finding a Cure for HIV Infection; Dyslipidemia; When to Start ART; Cervical Infection Drug Use; Antiretroviral Treatment of Adult HIV Infection
  • April/May 2010 (Issue 2) : CROI Highlights -- Advances in Basic Science; Vaccine Development; Epidemiology, Testing, and Prevention; Neurologic Complications; Complications of HIV Disease and ART; Advances in ART
  • February/March 2010 (Issue 1) : HIV Pathogenesis; Addiction Interventions in Primary Care; Dermatologic Manifestations

Volume 17

  • December 2009 (Issue 5) : Resistance Mutations Update; New ARVs, Formulations, and Strategies; Internet Resources
  • September/October 2009 (Issue 4) : Immune Dysfunction, Inflammation, and Aging; End-Stage Liver Disease; Cost-Effectiveness of HIV Interventions
  • July/August 2009 (Issue 3) : Cardiovascular Complications; Postexposure Prophylaxis; Updated Adult and Adolescent OI Guidelines
  • April/May 2009 (Issue 2) : CROI Highlights -- Basic Science Development; Vaccine Development; Epidemiology and Interventions; Neurologic Complications; Complications and ART; Advances in ART
  • February/March 2009 (Issue 1) : HIV and Travel; Review of Adherence and Intervention among Youth; When Silence Isn't Golden

Volume 16

  • December 2008 (Issue 5) : Resistance Mutations; Drug-Drug Interactions; MRSA Infections; Engagement in Care
  • October/November 2008 (Issue 4) : Resistance Profiles of New ARVs; Non-AIDS-Defining Malignancies; Renal Dysfunction and Tenofovir Toxicity; Lipodystrophy; ARV Treatment Recommendations
  • August/September 2008 (Issue 3) : Drug Resistance Testing Recommendations (reprint from CID)
  • June/July 2008 (Issue 2) : Starting ART; Insulin Resistance in HIV; Neurocognitive Disease; Psychiatric Disorders
  • April/May 2008 (Issue 1) : CROI Highlights -- Basic Science Summary; Vaccine Development; Testing and Prevention; Neurologic Complications; HIV Complications and Therapy; Advances in ART; Drug Resistance Mutations

Volume 15

  • November/December 2007 (Issue 5) : Sustaining Prevention; Resistance; Cardiovascular Risk and Management; Hepatitis B Coinfection
  • August/September 2007 (Issue 4) : Disease Progression; Novel Virologic Tests in Clinical Practice; Human Papillomavirus; Elite Control, Vaccines, and Treatments; Preconception Health Care; Mutations Update
  • June/July 2007 (Issue 3) : Bacterial Infections; Biomedical Prevention; Pharmacotherapy Issues in Sub-Saharan Africa
  • April/May 2007 (Issue 2) : CROI Highlights -- Basic Science Highlights; Epidemiology and Prevention Interventions; Neurologic Complications; Disease and Therapy Complications; Advances in ART
  • February/March 2007 (Issue 1) : HIV Infection in Women; HIV Testing Recommendations; Syphilis and Other STIs

Volume 14

  • December 2006/January 2007 (Issue 5) : Adult Immunizations; Primary Care; Renal Disease and Toxicities; Hepatitis B Coinfection
  • October/November 2006 (Issue 4) : Dyslipidemia and Other Cardiovascular Risk Factors; NRTI Options; Internet Dating Sites
  • August/September 2006 (Issue 3) : ART Failure; Structured Treatment Interruptions; Review of Depression Studies; Resistance Mutations; IAS Adult Treatment Recommendations
  • June/July 2006 (Issue 2) : Hepatitis B and C; Methamphetamine Use; Drug-Drug Interactions; Ryan White Reauthorization
  • March/April 2006 (Issue 1) : Developments in Basic Science; HIV Pathogenesis and Vaccine Development; Epidemiology and Prevention; Neurologic Complications; HIV Complications and ART; Advances in ART

Volume 13

Volume 12

  • December 2004-January 2005 (Issue 5) : PMTCT in Africa; Opportunistic Infections in the Caribbean; TB and HIV in the Caribbean
  • October/November 2004 (Issue 4) : How HIV Enters Cells; HIV and STIs; Disclosure and Safer Sex; Resistance Mutations; Adult ARV Treatment Recommendations
  • July/August 2004 (Issue 3) : Solid-Organ Transplantation in HIV-Infected Patients; Substance Use Disorders; Initiation of ART; Body Morphology Changes and Lipid Abnormalities
  • May/June 2004 (Issue 2) : Resistance and Replication Capacity Assays; STIs in HIV Care Setting; Reproduction Decision Making: Literature Review
  • March/April 2004 (Issue 1) : CROI Highlights -- Basic Science Research; Advances in ART; Complications of HIV and ART

Volume 11

  • November/December 2003 (Issue 6) : Review of Pediatric ART Guidelines; ART Adherence Interventions: Literature Review; Perinatal HIV: Special Considerations; Resistance Mutations
  • September/October 2003 (Issue 5) : Immune Reconstitution; ART: Recent Studies; Importance of STIs in HIV-Infected Persons; Resistance Testing IAS Recommendations
  • July/August 2003 (Issue 4) : Drug Transporters in HIV; Prevention Challenges in HIV Care; Strategic Approaches to ART; Resistance Testing Guidelines Panel Q&A
  • May/June 2003 (Issue 3) : CROI Highlights -- Opening Session; Basic Science Research; Pathogenesis and Vaccine Development; Complications of HIV and ART; Advances in ART; Resistance Mutations
  • March/April 2003 (Issue 2) : Advances in HIV Pharmacology; Anal Dysplasia Screening; Hepatitis C Management; Sex Differences in Adverse Reactions; Organizations for HIV Care in Developing Countries
  • January/February 2003 (Issue 1) : HIV Immune Response; Bone Disorders, Hypertension, and Mitochondrial Toxicity; HIV and Hepatitis B; Substance Abuse; Use of Club Drugs by Gay and Bisexual Men

Volume 10

  • November/December 2002 (Issue 5) : Initial ART; Resistance Management; Selected Issues in Pregnancy; Prevention and Management of Opportunistic Infections; Depression and Adjustment Disorder; Resistance Mutations
  • September/October 2002 (Issue 4) : HIV Pathogenesis and Antiviral Control; HIV Vaccine Research; ARV Drugs in Development; 2002 IAS Adult ARV Treatment Recommendations; WHO Guidelines for ART in Resource-Limited Settings
  • July/August 2002 (Issue 3) : Viral Binding and Fusion; Strategic Treatment Interruptions; ART: Panel Discussion of Clinical Cases; HIV in India
  • May/June 2002 (Issue 2) : CROI Highlights -- Pathogenesis and Vaccine Development; Resistance Mutations; HIV/HCV Coinfection; Incomplete Viral Suppression on ART; Therapeutic Drug Monitoring
  • March/April 2002 (Issue 1) : Highlights of Basic Science Research; Complications of HIV and Therapy; Management of ART; Managing Treatment Failure; Mitochondrial Toxicity of NRTIs; Switching ARVs for Metabolic Complications

Volume 9

  • December 2001 (Issue 6) : Key Updates from Recent Research Conferences; Science and Treatment of HIV/HCV Coinfection; Curtailing the HIV Epidemic: The Power of Prevention; Update on Drug Resistance Mutations
  • October 2001 (Issue 5) : Opioid Abuse and Treatment; HIV Prevention and Elimination of TB and Syphilis; HIV Pandemic; Q&A from IAS-USA Guidelines Panel; Epidemic Beginnings
  • August 2001 (Issue 4) : Evolving Approaches to Initial ART; Drug Resistance Testing; Coronary Artery Disease Risks with ART; The Story of Mary Fisher
  • July 2001 (Issue 3) : Pharmacology and Therapeutic Drug Monitoring; Lactemia and Bone Disease in HIV; Prevention among Seropositive Patients; Heterogeneity and Public Health in the Global Epidemic
  • June 2001 (Issue 2) : CROI Highlights -- HIV Pathogenesis and Vaccine Development; Fighting AIDS in Developing Countries; HIV-Associated Nephropathy; Disease Management in U.S. Latino Populations; Update on Resistance Mutations; Harvard Consensus Statement on ART in Poor Countries
  • March 2001 (Issue 1) : CROI Highlights -- Basic Science Research; Complications and Therapies; Management of ART

Volume 8

  • June 2000 (Issue 4) : Investigational Drugs in HIV Therapy; Initiation of ART; Issues in HIV Therapy in "Triple-Diagnosed" Patients; HIV Infection in Adolescents
  • May 2000 (Issue 3) : Strategies for Management of ARV Failure; New Development in HIV Care for Women; Postexposure Prophylaxis
  • March 2000 (Issue 2) : CROI Highlights -- Basic Science Research; Advances in Vaccines; Understanding Pathogenesis; Complications of HIV and ART; ART Update
  • February 2000 (Issue 1) : Reprint: Antiretroviral Therapy for HIV Infection in Adults: Updated Recommendations of the International AIDS Society-USA Panel

Volume 7

  • December 1999 (Issue 6) : Advances in Pathogenesis and Antiretroviral Therapy; Neurologic Manifestations of HIV; Antiretroviral Treatment During Pregnancy; HIV/Hepatitis C Coinfection
  • October 1999 (Issue 5) : Immune Reconstitution Strategies; Opportunistic Infections in the Era of Potent Antiretroviral Therapy; Metabolic Complications of Antiretroviral Therapy; HIV in Africa
  • September 1999 (Issue 4) : Early Steps in HIV Infection: Targets for Intervention; Discordant Responses to Therapy; Newer Antiretroviral Drugs; HIV in Africa
  • July 1999 (Issue 3) : Cellular Immune Response in HIV-1 Infection and Effects of Therapy on Immunologic Parameters; Status of the Thymus in adults HIV-1 Infection; New Developments in the Pathogenesis of HIV-1 Infection; Novel Targets for Antiretroviral Therapy
  • May 1999 (Issue 2) : Resistance Testing; Viral and Cellular Dynamics in HIV Disease; Treatment and Management of Antiretroviral Failures; Renal Complications
  • March 1999 (Issue 1) : Highlights from the 6th Conference on Retroviruses and Opportunistic Infections

Volume 6

  • January 1999 (Issue 6) : Update from the 12th World AIDS Conference and 1998 ICAAC Immunopathogenesis and Immune Reconstitution in HIV Disease Renal Complications in HIV Disease
  • October 1998 (Issue 5) : Special Report from the 12th World Conference on AIDS in Geneva: Discussions of the International AIDS Society-USA Panels on Resistance and Antiretroviral Therapy
  • September 1998 (Issue 4) : Primary HIV Infection; Issues in Antiretroviral Therapy; Adherence Strategies
  • July 1998 (Issue 3) : Antiretroviral Drug Resistance Testing in Adults with HIV Infection; Antiretroviral Therapy for HIV Infection in 1998
  • June 1998 (Issue 2) : Drug-Drug Interactions in the HIV-infected Patient; HIV Resistance to Antiretroviral Drugs; HIV Resistance to Antiretroviral Drugs
  • March 1998 (Issue 1) : Highlights from the 5th Conference on Retroviruses and Opportunistic Infections

Volume 5

  • September 1997 (Issue 3) : Recognition and Treatment of Primary HIV Infection; Current Status of Nonnucleoside Reverse Transcriptase Inhibitors; Adherence to Drug Regimens: A Learned Skill; The Impact of Treatment on the Production and Storage of HIV in Lymphoid Tissue
  • July 1997 (Special Issue) (Issue 2) : Updated Guidelines for Antiretroviral Therapy in 1997
  • June 1997 (Issue 1) : HIV Pathogenesis; Viral Load in Clinical Trials; Issues in Adherence; Pain Management

Volume 4

  • November 1996 (Special Issue) (Issue 1s) : Answers to Questions Posed to the 'Guidelines for Antiretroviral Therapy in 1996' Panel
  • September 1996 (Issue 3) : Advances in the Prevention and Treatment of Perinatal HIV Infection; Karposi's Sarcoma-associated Herpesvirus; Complementary Therapies in HIV Disease; HIV Resistance to Antiretroviral Drugs. insert: Antiretroviral Therapy for HIV Infection in 1996: Reccommendations of an International Panel
  • June 1996 (Issue 2) : HIV Pathogenesis; Occupational Risk of HIV Infection in Health Care Workers; Plasma HIV RNA Quantitation; Strategies for Continuing Antiretroviral Therapy; Drug Interactions with HIV Protease Inhibitors
  • April 1996 (Issue 1) : Initiation of Antiretroviral Therapy; Protease Inhibitors; Novel Therapies for HIV-1 Infection; Prevention of Opportunistic Infections; Treatment of Opportunistic Infections; Karposi's Sarcoma

Volume 3

  • August 1995 (Issue 2) : New Nucleoside Analogues and Nonnucleoside RTIs; Pathogenesis of HIV Infection; Protease Inhibitors; Pediatric HIV Infection
  • June 1995 (Issue 1) : Immunopathogenesis of HIV Infection; In Vivo Dynamics of HIV; Strategies for Continuing Antiretroviral Therapy; Antiretroviral Resistance and HIV Dynamics

Volume 2

  • August 1994 (Issue 2) : Pathogenesis of HIV Infection; Continuing Antiretroviral Therapy; Antiretroviral Resistance; HIV Disease in Women; Tuberculosis Management; Diarrhea Associated with HIV Disease; Developments in CMV Disease Treatment
  • June 1994 (Issue 1) : Health Care Worker Occupational Exposure to HIV; Immunopathogenesis of HIV Infection; Maternal-Fetal Transmission of HIV; Continuing Benefit from Antiretroviral Therapy; Opportunistic Infection Prophylaxis; Future Directions for Anti-HIV Therapy